Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOLLOLOL so funny
If you’re a shareholder and are holding, you should take some of your daddy’s money and buy more shares.
Or maybe you never sold any shares at a loss, averaged down, and sold into strength.
As a DECN shareholder, I'm very happy with Berman's leadership. Company is moving the needle in the right direction. Exciting times ahead of us.
The question was will the products ever be sold inside stores. Bozo Berman has put out press releases for years regarding this.
ARE WE EVER GOING TO SEE PRODUCTS ON MAJOR STORE SHELVES???
Yes, I am a very happy shareholder. Not only have I not lost any money in DECN, I have made money.
Company has issued options to purchase common, seems okay to me. It's their right to do so. I would imagine if someone was not okay with this, they would not invest in DECN.
What is not okay however is accusing people in a public forum of a crime without any evidence or showing proof. This is a crime in itself.
After being around for 17 plus years and losing MILLIONS OF DOLLARS OF INVESTORS MONIES that should at least BORDER on ILLEGAL!!
Very happy shareholder here.
Excellent news today. Keep up the good work DECN and Berman!
Company continues to move forward.
DECN has news out this morning.
Johnnny, have you ever spoken to Berman?
You surely have a lot to say here, seems logical you’d calll and speak to him.
Does Bozo Berman have 2 brothers from the same mother? Trust fund baby? Lol.
Where did that big buyer go. Lol
How many shares did daddy sell into the flurry? He owned how many, 12 million? If daddy sold his shares, that would have made him the big seller. That would make sense given the vitriol by TAUG's failed paid consultant. And if daddy didn't sell, why not? Doesn't he take advice from TAUG's failed paid consultant?
In 2018 the company has accomplished the following milestones.
1. We completed the design and manufacture of PetSure! glucose test strips for the international markets, and completed development of our GenChoice!, GenUltimate! 4Pets and GenUltimate! TBG products.
2. We began FDA 510K prosecution, patient clinical, 3 rd Party testing and/or clinical trials of two new test strip products, our GenChoice! and GenUltimate! TBG test strips and the GenUltimate! TBG Precise meter. Neither the PetSure! nor GenUltimate! 4Pets products required live patient (pet) clinical testing.
3. We are pressing our suit against Johnson & Johnson and several divisions for manufacturing products that infringe on our patents. We won a major early battle in this suit where the trial judge granted us the opportunity to argue the Doctrine of Equivalents, an important concession in this case given J&J’s penchant for the twisting of words and drawing lines through random dots. We lost a mid-stream battle and are now appealing to a court where we have had major rulings in our favor in the past. This suit began its prosecution phase on March 15, 2017 with the trial judge’s early ruling. We filed our appeal in the United States Federal Circuit Court of Appeals (the patent court) and expect oral arguments to commence and a mediation in June 2019.
4. The company initiated a marketing program to the on-line Marketplaces sponsored by pharmacy chain, department store and grocery store retailers, as well as mass merchandisers, and including the largest retailers. This program has so far been the most successful endeavor since our inception.
Did the self serving golden cross become a DECN golden shower?
Amazing how this goes on. But you know, real guys don’t read message boards. And the people that do can see the paper trail of garbage these individuals left.
Especially when the man the poster is putting down is a guy the poster has never met, spoken to or corresponded with.
You have been making serious accusations toward DECN and Berman. Please back up with evidence if you want to be taken seriously. Otherwise this is just some hot air.
I would also like some proof, Mugsy. You’re making some pretty serious statements. If you want to be taken seriously you need to provide evidence. Otherwise it’s just more hot air.
I never seen such a thing, this place is very comical.
Oh wow. Really? Lol I can’t even argue with that logic. LMAO.
Many others too!
was already hit for 10k earlier today. Went down to 1.99 million from 2 million.
It’s a real bid bud .
I have to agree with you. He doesn't.
Big buyer buyer is back! Look that, who can it be?
The big buyer is indeed back! Thank you for sharing!
Charts mean nothing with a on reporting trade by appointment stock like DECN.
Please explain:
MASSIVE DILUTION COMING!!!!!!!!!!!
I love PetSmart. They actually let you bring your dog in there on a leash and walk them around. I always bring our Siberian Husky there to meet other dogs. Nice to know I will be able to purchase DECN product there now.
Very nice
“The terms of the loan are standard. There is no convertible feature.”
I'm thinking the same thing also. Sales, manufacturing, distribution, retail presence.
I really like their manufacturing, the quality is of very high quality. Instructions are in multiple languages also, pretty smart.
With big name retailers, they certainly will be growing their top line sales. Couldn't be happier with the product.
It's funny how retailers are. If one retailer has it, another retailer wants it also.
Certainly there is a a big air pocket here above us. A lot of room for a run up.
Thank you for the technical analysis.
Exciting times ahead of us as DECN shareholder. Thank you again.
Glad I was averaging down all this time. Way to go DECN and Berman. I will continue to hold my shares, we haven't seen anything yet. Like I said last week, when there is smoke, there is fire. Read between the lines here. Berman is using very strong language here in these PR's. This is consistent with language that was used earlier this year and late last year. When there is smoke, there is fire. Holding shares, not selling a dime. Why be penny wise, dollar foolish? Good luck to all!
Company Moves to Next Step, Builds Foundation for Increased Revenues, Branding And Positioning, as Well as a Handsome Settlement or M&A Transaction
LOS ANGELES, CA / ACCESSWIRE / March 12, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is a 16 year old diabetes focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for a growing brand of alternatives to legacy diabetic, proprietary, and pet testing glucose test strips.
Decision Diagnostics is pleased to announce and communicate that we have recently entered into a long term relationship with PARAGON Sales and Marketing Inc. to support the national growth of both our branded and private label retail products sold under our "Gen" brand, and our private label brands of Alltara!, ConsumerValue!, Infatig!, and Medicius!. Initial accounts that we have assigned to PARAGON for big box and private brand big box agreements include Walmart, CVS, Walgreens, Costco and Cardinal Health. PARAGON will also work closely with us in evaluating other potential new retail product categories and products that we may launch in both branded and private label offerings in the future.
Keith Berman, CEO of DECN commented, "Now that we have established our "Gen" technologies to the stage where we can comfortably direct our focus to the more traditional sales channels. Although never absent from our planning and operations, many intended activities and associations were held in abeyance until were confident that our "Gen" brand had been fully accepted in the market and our pricing structure stable. With our market prices now on the upswing we no longer now need to be restrained. We are beginning a full scale frontal assault on the domestic retail market immediately starting with the world's largest retailer, who by the way is already a customer.
The four year agreement with PARAGON charges them with executing and managing DECN's existing massive retail contract; completing negotiations and finalizing agreements in varied degrees of completion; introducing the company's "Gen" family of diabetic test stripsto unexplored retail venues, and pursuing opportunities in newretail markets."
Chuck Deem, President & CEO of PARAGON continued, "DECN's PharmaTech Solutions subsidiary is an ideal client for PARAGON at the optimum moment in the test strip channel. The big box retail space is now ready to embrace the "Gen" line of products and advance them throughout the retailenvironment. PharmaTech's management and staff are deeply experienced with impressive success in developing products for a market that is still growing by leaps and bounds, moving brands from obscurity to presence, growth and rapid expansion. They know the business intimately; and we have existing business and personalrelationships throughout the organizational chains of the primary US retailers and boast extraordinary sales results with each of their clients."
Product Development Updates
Our GenChoice! ("Ladybug") was submitted for FDA 510K clearance during the government shutdown. Subsequently the company has received two staff follow up letters from the FDA, the most recent letter informing the company last week that its 510K application has passed an FDA review milestone and has been moved to the FDA's substantive review team. We are pleased that we have moved from the initial review phase to the substantive phase in approximately 45 days. This event bodes well for 510K clearance.
Our GenUltimate! and the GenUltimate! TBG Precise Meter ("Dragonfly") remain the company's most exciting new product additions and those that have the highest ceilings. Product development and advanced testing have just been completed, and patient clinical trials are in the process of being scheduled in Korea. The GenUltimate! TBG product will capitalize on the GenUltimate! technology foundation, but will also feature two technologies that correct hematocrit, one new, the other somewhat traditional, that will deal with the largest interfering substance (red blood cells) in at home glucose measurements. GenUltimate! TBG will be the company's first complete system product for human diabetics; one that includes the test strips and the meter. The TBG product will set a new standard for glucose measurement precision by offering precision at the +/- 8% level. We have had discussions with one legacy manufacturer and plan to contact with the other in the next several weeks.
The company has launched its proprietary GenUltimate! 4Pets (the "Carnation") product over the past two weeks. This product includes our GenUltimate test strips calibrated for use on dogs, cats, and horses. The GenUltimate! 4Pets system also includes a meter, the first meter developed by the company for commercial sale. GenUltimate! 4Pets joins our PetSure! test strips designed to run on Alpha Trak meters by Zoetis. Our line of pet testing products are the most complete solutions in the pet testing market.
Mr. Berman concluded, "We will provide individual updates for each product discussed above in the coming days. In addition we will discuss in detail all product additions, changes and growth in our upcoming Annual Report for FY2018."
About Decision Diagnostics Corp
Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With new inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $12 billion at-home testing market.
Forward-Looking Statements
This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of March 11, 2019, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.
Contact Information:
Decision Diagnostics Corp.
Keith Berman (805) 446-2973
info@decisiondiagnostics.com
www.genultimate.com
www.genultimate4pets.co
www.petsureteststrips.com
www.pharmatechdirect.com
Nice work, very exciting time to be a DECN shareholder.
Bakerco,you must be a new investor here .02 cents,most of investors in this company have lost almost all of our monies over the past years and are not happy with all the hyped press releases and nothing ever comes of it!!Their failures have been presented a number of times on this board.Stick around long enough and you will feel the same way we do with the LACK OF RESULTS under berman/bod(if they even have a board)!!!!!!!!!! WILL WE EVER SEE STRIPS ON STORE SHELVES? Have a good weekend
5 Trades = $1.5k and closed down...
Hope you give us more research about a potential hedge fund buying DECN. LOL
It is amazing how nobody knows anything about it but you. Generally, things get leaked and trading volume rises. Where did you do your research, in DECN's PA office...Opps, they don't have one! Maybe in DECN's condo in CA.
Maybe you need to do some more research on Bozo berman. Oh, but perhaps you know him very very well after all.
DECN investors have been hosed with reverse splits, BS press releases and massive dilution.
]Is that simple enough. I have no need to audio communicate with Bozo Berman, his aliases or you...